NEW YORK (GenomeWeb News) – Cancer geneticist Janet Rowley has died at the age of 88, according to the University of Chicago, where she discovered genetic aberrations involved in leukemia, which led to new treatments such as Gleevec (imatinib).

The University noted this week that Rowley made a series of fundamental discoveries during her career that demonstrated how specific chromosomal changes caused certain types of cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times' George Johnson muses on cancer's roots in multicellularity.

The San Diego Union Tribune wonders whether Medicare is ready for personalized medicine.

Jun Wang, the chief executive of BGI, has stepped down.

In PNAS this week: human T cell editing with CRISPR, retrotransposons acting as insulators, and more.